Arix Taps Australia's 'Undervalued' Pharmaxis As First VIPE, More Planned

 
• By Sten Stovall
Incubator Fund Arix takes an 11% stake and board seat at Pharmaxis • Source: Shutterstock

More from Financing

More from Business